A patient with subacute cutaneous lupus erythematosus along Blaschko lines: Implications for the role of keratinocytes in lupus erythematosus  by Yu, Sebastian & Yu, Hsin-Su
lable at ScienceDirect
DERMATOLOGICA SINICA 34 (2016) 144e147Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCASE REPORTA patient with subacute cutaneous lupus erythematosus along
Blaschko lines: Implications for the role of keratinocytes in lupus
erythematosus
Sebastian Yu 1, 2, Hsin-Su Yu 1, 3, *
1 Department of Dermatology, Kaohsiung Medical University Hospital, and Department of Dermatology, College of Medicine, Kaohsiung Medical University,
Kaohsiung, Taiwan
2 Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
3 National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County, Taiwana r t i c l e i n f o
Article history:
Received: Jul 24, 2015
Revised: Nov 29, 2015





linear cutaneous lupus erythematosus
Ro antigenConﬂicts of interest: The authors declare that the
ﬁnancial conﬂicts of interest related to the subject m
in this article.
* Corresponding author. National Health Research
Zhunan Town, Miaoli County 35053, Taiwan.
E-mail address: yup.kmu@gmail.com (H.-S. Yu).
http://dx.doi.org/10.1016/j.dsi.2015.12.002
1027-8117/Copyright © 2016, Taiwanese Dermatologic
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Blaschko lines are manifestations of cutaneous mosaicism, with apparent contrast between normal cells
and abnormal cells, which carry postzygotic mutations. Linear cutaneous lupus erythematosus is a rare
subset of cutaneous lupus erythematosus (CLE), characterized by skin lesions along Blaschko lines. In this
paper, we presented a 47-year-old female with subacute CLE lesions along Blaschko lines. Although the
antinuclear antibody and anti-Ro titers were remarkably high, there were no systemic symptoms. The
histopathology showed atrophic epidermis with vacuolization of basal keratinocytes and papillary
edema. While no typical linear lupus band was found, the direct immunoﬂuorescence revealed cytoid
bodies with immunoglobulin G, immunoglobulin M, C3, and C4 depositions in the papillary dermis. The
skin lesions completely resolved after topical tacrolimus treatment, and the clinical course was 10
months without recurrence. We reviewed the literature and summarized that CLE along Blaschko lines
supports the functional role of Ro antigens and keratinocytes in the development of CLE.
Copyright © 2016, Taiwanese Dermatological Association.
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Linear cutaneous lupus erythematosus (LCLE) is a rare subset of
cutaneous lupus erythematosus (CLE), characterized by skin lesions
that follow Blaschko lines.1 However, there are a variety of de-
scriptions of lupus erythematosus (LE) lesions in these cases,
including discoid LE and LE profundus among others. Although
there is one case with other organ involvement that fulﬁlled the
diagnostic criteria of systemic lupus erythematosus (SLE),2 cuta-
neous lesions are the only manifestation in most of the LCLE cases.
In this paper, we presented a female patient with LCLE. We dis-
cussed the origin of Blaschko lines and summarized that CLE alongy have no ﬁnancial or non-
atter or materials discussed
Institutes, 35, Keyan Road,
al Association. Published by ElseviBlaschko lines supports the functional role of keratinocytes in the
development of CLE.
Case report
A 47-year-old female presentedwith a 2-month history of scattered
pigmented macules over her right waist. The lesions were neither
pruritic nor painful. She had neither trauma history nor associated
symptoms. She had no known underlying systemic disease except
thalassemia. A complete blood count showed microcytic anemia,
compatible with thalassemia. The antinuclear antibody (ANA) was
weakly positive (1:40). One month later, however, the pigmented
lesions became scaly and papular, progressing toward the right
lower extremity. The lesions were arranged in arch shapes on the
right waist (Figure 1A) and in linear conﬁguration on the right
lower extremity (Figure 1B). A skin biopsy was performed. The
histopathology showed atrophic epidermis with vacuolization of
basal keratinocytes and papillary edema. Scattered dyskeratotic
cells in papillary dermis were also found. There was inﬂammatory
lymphocytic inﬁltration around the vascular structure ander Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 The pigmented papular scaly lesions on the right abdomen and right leg. (A) The ﬁgure shows lesions were arranged in arch shapes on the right side of the waist; (B) the
ﬁgure shows lesions were in linear conﬁguration on the right lower extremity; (C) the ﬁgure shows histopathology at the junction between the lesional (left side) and perilesional
skin (right side). In the lesional skin, there was atrophic epidermis with vacuolization of basal keratinocytes and papillary edema. Scattered dyskeratotic cells were also found in
papillary dermis; (D) the ﬁgure shows there was periadnexal lymphocytic inﬁltration; and (E) the ﬁgure shows cytoid bodies of immunoglobulin G in the papillary dermis in direct
immunoﬂuorescence examination.
S. Yu, H.-S. Yu / Dermatologica Sinica 34 (2016) 144e147 145melanophages in the upper dermis (Figure 1C). Periadnexal lym-
phocytic inﬁltration was also observed (Figure 1D). The histo-
pathologic ﬁndings were compatible with LE.3,4 Direct
immunoﬂuorescence revealed cytoid bodies with immunoglobulin
G, immunoglobulin M, C3, and C4 depositions in the papillary
dermis (Figure 1E). ANA was followed up and showed >1:1280
positive. Other autoantibody surveys showed anti-Ro positive (80.6
EliAU/mL, normal <7), anti-La negative, antiphospholipid immu-
noglobulin M and immunoglobulin G negative, and rheumatoid
factor negative. The viral-infection survey showed negative for
herpes simplex virus, varicella-zoster virus, and EpsteineBarr virus.
Based on the clinical manifestation, histopathology, and autoanti-
body ﬁndings, subacute cutaneous lupus erythematosus (SCLE)
along Blaschko lines was diagnosed. Because there were no sys-
temic symptoms, topical treatment with 0.1% tacrolimus ointment
was prescribed without oral medication. After a 5-month topical
tacrolimus treatment, the skin lesions gradually resolved (Figure 2).The autoantibody survey was followed up again and showed ANA
>1:1280 positive. The anti-Ro titer slightly decreased (51.3 EliAU/
mL, normal <7) as compared to the previous anti-Ro titer. The
topical treatment was continued, and the skin lesion resolved with
complete clearance. No scaring or skin atrophy was noted. The total
clinical course was 10 months.
Discussion
The ﬁrst case of discoid LE with linear distribution along Blaschko
lines was reported by Umbert and Winkelmann in 1978.5 In 1998,
the term LCLE was proposed by Abe et al1 to describe discoid LE
with linear conﬁguration following Blaschko lines. From then on,
several papers reported patients with LE lesions along Blaschko
lines. In addition to linear discoid LE, some cases were diagnosed as
linear LE profundus,6e9 and onewas diagnosed as linear tumid LE.10
In 2006, R€ockmann et al11 reported a female with SCLE on Blaschko
Figure 2 Clinical photos at 8 months (i.e., after topical tacrolimus treatment for 5
months). (A) The papular scaly lesions on the right abdomen and (B) the right lower
extremity ﬂattened and disappeared gradually (as shown in circles).
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lines reported to date. Because the spectrum of CLE lesions is wide
and because different CLE subsets share some similarities,12 some
cases were designated as linear LE without speciﬁc subtypes.13e15
In a report presented by Lee et al,14 the term LCLE was used to
describe LE lesions associated with Blaschko lines, regardless of
their LE subtypes. In addition, linear conﬁguration does not
necessarily mean Blaschkoid distribution. For example, zosteriform
distribution, which reﬂects dermatome, is also linear. Therefore,
the term “Blaschkoid CLE” instead of linear CLE may more specif-
ically describe the skin lesions.
ANAwas positive in some of those patients with Blaschkoid CLE.
Among those ANA-positive cases, two showed positive for other
autoantibodies. In a female case reported by R€ockmann et al,11 ANA
was 1:2560 and anti-Ro was positive. The papulosquamous lesions
were distributed along Blaschko lines on the right side of her trunk
to her right leg and foot without systemic symptoms. The distri-
bution of skin lesions and pathological ﬁndings were similar to ourcase. After treatment with systemic corticosteroids and chloro-
quine, the skin lesions improved without progression to SLE.11 In
another male case presented by Heid et al,13 ANA was 1:1280 and
anti-ribonucleoprotein was positive. The unilateral skin eruption
was distributed on his right chest, the axillary area, and the arm.
CLE was described, but no speciﬁc subtype was indicated by the
authors. The eruption lasted for 6 months and regressed sponta-
neously.13 Similar to our present case, Blaschkoid lesions in these
two reported cases resolved without progression to SLE or associ-
ated systemic symptoms despite the high autoantibody titers.
Blaschko lines are attributed to the clonal proliferation of
genetically distinct ectodermal cells that develop from postzygotic
mutation during embryogenesis.16,17 Paller et al18 demonstrated
that Blaschko lines represent genetic mosaicism in keratinocytes.
The cases of CLE along Blaschko lines highlight the functional roles
of keratinocytes in the pathogenesis of LE. A growing body of
literature supports that keratinocytes participate in the initiation of
LE. After UV irradiation or chemical exposure, damaged keratino-
cytes secrete proinﬂammatory cytokines and chemokines, upre-
gulate Ro antigen expression on the cell membrane, and undergo
apoptosis.19,20 Speciﬁcally, cytoplasmic Ro52 was upregulated in
keratinocytes in CLE, which in turn contribute to Ro52-associated
autoimmunity and keratinocyte apoptosis. It could be hypothe-
sized that genetic mutation of Ro52 or Ro52 upregulation-
associated gene in localized keratinocytes predisposes these
mutated keratinocytes to autoimmune response, which accounts
for the Blaschkoid distribution in these CLE cases. This hypothesis is
supported by the direct immunoﬂuorescence ﬁnding in our case.
Cytoid bodies, which represent apoptotic keratinocytes with
attached immunoglobulins and/or complements,21 were observed
in our case, while there was lack of linear lupus band at basement
membrane, which is typical of SLE.22 In addition, the only clinical
manifestation of our case was Blaschkoid skin lesions in spite of
high ANA and anti-Ro titers in active stage. Indeed, polymorphisms
of the Ro52 gene have been associated with SLE23 and primary
Sj€ogren's syndrome,24 another autoimmune disease that shows an
overlapping entity with LE.
It is noteworthy that our case responded well to topical tacro-
limus. Although the role of T cells in LE remains to be elucidated, a
growing body of literature indicates that T cells are involved in the
pathogenesis of LE.20 The successful treatment in our case high-
lights T cells as a potential therapeutic target in CLE.
In conclusion, we presented a female with CLE lesions along
Blaschko lines. The histopathology, immunoﬂuorescence, and
autoantibody survey conﬁrmed the diagnosis of SCLE. To our
knowledge, this is the only reported Taiwanese case with CLE along
Blaschko lines. Although the ANA and anti-Ro titers were remark-
ably high, there was no systemic symptom. The skin lesions
responded well to topical tacrolimus. Because Blaschko lines
represent genetic polymorphisms in keratinocytes, CLE lesions
following Blaschko lines indicate the functional role of keratino-
cytes in the initiation of LE. We also suggest the new term
“Blaschkoid CLE” to encompass all CLE following Blaschko lines
regardless of their subtypes.References
1. Abe M, Ishikawa O, Miyachi Y. Linear cutaneous lupus erythematosus following
the lines of Blaschko. Br J Dermatol 1998;139:307e10.
2. Roholt NS, Lapiere JC, Wang JI, Bernstein LJ, Woodley DT, Eramo LR. Localized
linear bullous eruption of systemic lupus erythematosus in a child. Pediatr
Dermatol 1995;12:138e44.
3. Chen YC, Wu YH. Ticlopidine-induced subacute cutaneous lupus erythemato-
sus: a case report and literature review. Dermatol Sin 2014;32:183e6.
4. Tsai CF, Lee HC, Chu CY. Sarcoidal alopecia mimicking discoid lupus erythe-
matosus: report of a case and review of the literature. Dermatol Sin 2014;32:
43e6.
S. Yu, H.-S. Yu / Dermatologica Sinica 34 (2016) 144e147 1475. Umbert P, Winkelmann RK. Concurrent localized scleroderma and discoid
lupus erythematosus. cutaneous “mixed” or “overlap” syndrome. Arch Dermatol
1978;114:1473e8.
6. Tada J, Arata J, Katayama H. Linear lupus erythematosus profundus in a child.
J Am Acad Dermatol 1991;24:871e4.
7. Tamada Y, Arisawa S, Ikeya T, Yokoi T, Hara K, Matsumoto Y. Linear lupus er-
ythematosus profundus in a young man. Br J Dermatol 1999;140:177e8.
8. Tamiya H, Sowa J, Nakanishi T, Adachi M, Ishii M, Kobayashi H. Linear lupus
erythematosus profundus on the face, following the lines of Blaschko. Int J
Dermatol 2010;49:1459e61.
9. Nagai Y, Ishikawa O, Hattori T, Ogawa T. Linear lupus erythematosus pro-
fundus on the scalp following the lines of Blaschko. Eur J Dermatol 2003;13:
294e6.
10. Pacheco TR, Spates ST, Lee LA. Unilateral tumid lupus erythematosus. Lupus
2002;11:388e91.
11. R€ockmann H, Feller G, Schadendorf D, Goerdt S. Subacute cutaneous lupus
erythematosus on the lines of Blaschko. Eur J Dermatol 2006;16:302e6.
12. Wenzel J, Zahn S, Tuting T. Pathogenesis of cutaneous lupus erythematosus:
common and different features in distinct subsets. Lupus 2010;19:1020e8.
13. Heid E, Grosshans E, Gonda J, Pare M, Lipsker D. [Blaschkolinear eruption with
biological signs of lupus]. Ann Dermatol Venereol 1996;123:331e3.
14. Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. Linear cutaneous lupus erythe-
matosus in the lines of Blaschko. Pediatr Dermatol 2001;18:396e9.15. Sabat M, Ribera M, Bielsa I, Mangas C, Fernandez-Chico N, Ferrandiz C. Linear
lupus erythematosus following the lines of Blaschko. J Eur Acad Dermatol
Venereol 2006;20:1005e6.
16. Happle R. Mosaicism in human skin. Understanding the patterns and mecha-
nisms. Arch Dermatol 1993;129:1460e70.
17. Molho-Pessach V, Schaffer JV. Blaschko lines and other patterns of cutaneous
mosaicism. Clin Dermatol 2011;29:205e25.
18. Paller AS, Syder AJ, Chan YM, et al. Genetic and clinical mosaicism in a type of
epidermal nevus. N Engl J Med 1994;331:1408e15.
19. Oke V, Wahren-Herlenius M. Cutaneous lupus erythematosus: clinical aspects
and molecular pathogenesis. J Intern Med 2013;273:544e54.
20. Yu C, Chang C, Zhang J. Immunologic and genetic considerations of cutaneous
lupus erythematosus: a comprehensive review. J Autoimmun 2013;41:34e45.
21. Wu YH, Lin YC. Cytoid bodies in cutaneous direct immunoﬂuorescence ex-
amination. J Cutan Pathol 2007;34:481e6.
22. Alahlaﬁ AM, Wordsworth P, Wojnarowska F. The lupus band: do the autoan-
tibodies target collagen VII? Br J Dermatol 2004;150:504e10.
23. Frank MB, Itoh K, Fujisaku A, Pontarotti P, Mattei MG, Neas BR. The mapping of
the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its
polymorphisms. Am J Hum Genet 1993;52:183e91.
24. Nakken B, Jonsson R, Bolstad AI. Polymorphisms of the Ro52 gene associated
with anti-Ro 52-kd autoantibodies in patients with primary Sjogren’s syn-
drome. Arthritis Rheum 2001;44:638e46.
